Multiple Sclerosis and Related Disorders
Scope & Guideline
Innovating treatment strategies for related disorders.
Introduction
Aims and Scopes
- Clinical and Epidemiological Research:
The journal emphasizes studies that explore the clinical characteristics, epidemiology, and natural history of multiple sclerosis, providing valuable insights into the disease's progression and factors influencing its course. - Therapeutic Advances and Treatment Protocols:
It covers research on the efficacy and safety of disease-modifying therapies (DMTs) and other treatment modalities, including novel therapies, their impact on quality of life, and management strategies for MS and related disorders. - Neuroimmunology and Pathophysiology:
Research on the underlying immunological mechanisms and neurobiological changes associated with MS is a key focus, aiming to enhance understanding of disease mechanisms and identify potential therapeutic targets. - Patient-Reported Outcomes and Quality of Life:
The journal prioritizes studies that assess patient-reported outcomes, including quality of life, mental health, and the psychosocial impacts of living with MS, emphasizing a holistic approach to patient care. - Innovative Diagnostic Techniques:
Research exploring advanced diagnostic tools and biomarkers for MS, including imaging techniques and laboratory assays, is highlighted to improve diagnostic accuracy and patient stratification. - Multidisciplinary Approaches to Care:
The journal promotes studies that investigate the effectiveness of multidisciplinary care models, including rehabilitation, physical therapy, and psychological support for MS patients.
Trending and Emerging
- Impact of COVID-19 on MS Patients:
Research exploring the effects of COVID-19 on MS patients, including vaccine responses and disease management during the pandemic, has surged, reflecting the urgency of understanding this intersection. - Telemedicine and Remote Care Models:
There is a growing emphasis on studies evaluating telehealth interventions and their effectiveness in managing MS, driven by the need for accessible care during the pandemic. - Neuropsychological and Cognitive Function Studies:
Increased attention is being given to the assessment and management of cognitive impairment in MS patients, focusing on innovative interventions and understanding the neuropsychological aspects of the disease. - Patient-Centered Care and Shared Decision-Making:
Research highlighting the importance of patient perspectives, shared decision-making, and personalized care approaches is gaining traction, indicating a shift towards more holistic and inclusive treatment strategies. - Biomarkers and Predictive Modeling:
Emerging studies focusing on biomarkers, such as neurofilament light chains, and their role in predicting disease progression and treatment response are trending, reflecting advancements in precision medicine. - Lifestyle Interventions and Holistic Approaches:
There is an upward trend in research examining the impact of lifestyle factors, including diet and exercise, on MS symptom management and overall health outcomes, emphasizing a comprehensive approach to care.
Declining or Waning
- Basic Science Research:
There appears to be a declining focus on basic science studies that explore fundamental biological mechanisms of MS, as the journal increasingly prioritizes clinical and translational research. - Historical Epidemiological Studies:
Research focusing solely on historical epidemiological trends without contemporary relevance may be waning, as the journal shifts towards studies that provide actionable insights for current clinical practice. - Single-Disorder Focus:
There is a noticeable reduction in publications that focus exclusively on multiple sclerosis, with a growing trend towards comparative studies involving related disorders, such as neuromyelitis optica spectrum disorders. - Pharmacovigilance Studies without Clinical Implications:
Studies that examine adverse drug reactions in isolation, without linking findings to clinical outcomes or treatment strategies, have become less common.
Similar Journals
NEUROLOGIST
Empowering Neurology Through Cutting-Edge ResearchNEUROLOGIST, an esteemed journal published by Lippincott Williams & Wilkins, serves as a vital resource in the fields of Neurology and Medicine. With an ISSN of 1074-7931 and an E-ISSN of 2331-2637, this journal has been dedicated to advancing the understanding of neurological disorders since its inception in 1996, with continual contributions through 2024. Achieving a respectable Q3 rank in both Medicine (miscellaneous) and Neurology (clinical), it provides an essential platform for disseminating innovative research and clinical studies. Although it is not an open-access publication, NEUROLOGIST promotes a rich exchange of ideas and findings for researchers, healthcare professionals, and students alike, helping to bridge the gaps in neurological research and practice. The journal is recognized for its commitment to enhancing clinical practice and research methodology, making it a valuable asset for anyone engaged in the dynamic field of neurology.
LANCET NEUROLOGY
Innovative Discoveries for Tomorrow's NeurologistsThe Lancet Neurology is a premier academic journal published by Elsevier Science Inc, specializing in the field of neurology. With a robust impact factor that signifies its authoritative presence, it consistently ranks in the Q1 category for clinical neurology according to the 2023 standards, positioning itself as the leading journal in its domain, ranking #1 out of 400 in Scopus' neurology rankings and placing in the 99th percentile. Since its establishment in 2002, it has provided a vital platform for disseminating innovative research and clinical advances related to neurological disorders. The journal’s precise focus includes cutting-edge studies on neurodegenerative diseases, stroke, epilepsy, and neuroimaging, which are essential for advancing clinical practice and improving patient outcomes. While it does not offer open access, readers can find high-impact research published monthly, making it indispensable for practitioners, researchers, and students eager to stay at the forefront of neurological science.
Turkish Journal of Neurology
Connecting minds to unravel the complexities of the brain.Turkish Journal of Neurology, published by GALENOS PUBL HOUSE, is a pivotal open-access journal established in 2004, dedicated to advancing the field of neurology. Renowned for its inclusive approach, this journal serves as a vital platform for researchers and clinicians to share their findings and insights related to neurological disorders and clinical practices, with an emphasis on enhancing the understanding of various neurological conditions affecting populations in Turkey and beyond. Although it holds a Q4 rank in Neurology (Clinical) as per the 2023 category quartiles, the journal's commitment to fostering knowledge exchange remains steadfast, aiming to bridge gaps in clinical research and practice. With an ISSN of 1301-062X and an E-ISSN of 1309-2545, it is indexed in Scopus, ranking 349 out of 400, reflecting its growing presence in the academic sphere. Located in Istanbul, Turkey, the journal invites submissions from both emerging and established researchers to contribute to its diverse content, thereby enhancing its impact on the local and international neurology community.
NEUROLOGY
Elevating standards in clinical neurology.NEUROLOGY, published by Lippincott Williams & Wilkins, stands as a premier journal in the field of neurology, holding an esteemed Q1 category ranking in clinical neurology as of 2023. Established in 1951, this journal has been a critical resource for the dissemination of cutting-edge research and clinical advancements, with an impressive Scopus rank of 24 out of 400, placing it in the 94th percentile among its peers. NEUROLOGY serves as a vital platform for neurologists, researchers, and medical professionals seeking to stay abreast of the latest findings and innovations in the treatment and understanding of neurological disorders. With its rigorous peer-review process and commitment to excellence, NEUROLOGY remains essential reading for all individuals dedicated to advancing the science and practice of neurology, contributing significantly to the ongoing dialogue in this vital area of medicine.
REVUE NEUROLOGIQUE
Driving Innovation in Neurological Disorders and TreatmentsREVUE NEUROLOGIQUE, published by MASSON EDITEUR, is a prestigious academic journal that plays an essential role in the field of neurology. With a rich history spanning from 1946 to the present, this journal focuses on both foundational and clinical aspects of neurology, underscoring its significance within the medical community. Holding an impressive Q2 ranking in both general and clinical neurology categories as of 2023, REVUE NEUROLOGIQUE is recognized for its contribution to advancing neurological science, as evidenced by its Scopus rankings, with a notable position in the 62nd percentile for clinical neurology. The journal fosters an environment for rigorous research and is instrumental for professionals and scholars aiming to stay abreast of the latest developments in neurological disorders and treatments. Although it is not an open-access publication, it offers a wealth of vital research through its issues, appealing to those engaged in both clinical practice and academic research in neurology.
ACTA NEUROLOGICA SCANDINAVICA
Unveiling New Perspectives in Neurological ScienceACTA NEUROLOGICA SCANDINAVICA is a prestigious journal published by Wiley that has significantly contributed to the field of neurology and neuroscience since its inception in 1961. With a broad scope encompassing clinical and experimental research, this journal is esteemed for its rigorous peer-review process and high-quality publications. Located in the United Kingdom, it is recognized in the 2023 category quartiles as Q1 in Medicine (miscellaneous) and Q2 in both Neurology and Clinical Neurology, indicating its strong influence and relevance within the medical community. With an H-index demonstrating consistent citation impact, ACTA NEUROLOGICA SCANDINAVICA holds a Scopus rank of #86 out of 400 in Clinical Neurology, reflecting its contribution to advancing current knowledge and practice. Researchers, professionals, and students alike will find in this journal a valuable resource for the latest findings, discussions, and developments in understanding neurological disorders and treatments, furthering educational and clinical endeavors alike.
NEUROMUSCULAR DISORDERS
Empowering researchers with cutting-edge discoveries.NEUROMUSCULAR DISORDERS is a premier academic journal published by PERGAMON-ELSEVIER SCIENCE LTD, focusing on the latest research and developments in the fields of neurology, genetics, and pediatric health. With an ISSN of 0960-8966 and an E-ISSN of 1873-2364, this journal has established a significant presence since its inception in 1991, and it continues to contribute to the scientific community with its impactful findings and reviews. The journal boasts a commendable impact factor, reflected in its placement in the Q2 category for Clinical Genetics and Neurology, as well as its positioning in the top tier Q1 for Pediatrics, Perinatology and Child Health according to the latest quartile assessments. With Scopus rankings such as Rank #71/330 in Pediatrics and Rank #51/99 in Clinical Genetics, NEUROMUSCULAR DISORDERS is recognized for its contribution to advancing knowledge in neuromuscular diseases. The journal is essential for researchers, clinicians, and students interested in the intricate relationship between genetics and neurological disorders, providing valuable insights that drive innovation and improve patient care.
Therapeutic Advances in Neurological Disorders
Connecting researchers and practitioners in the realm of neurology.Therapeutic Advances in Neurological Disorders, published by SAGE Publications Ltd, is a leading open access journal dedicated to the advancement of knowledge in the field of neurology. Since its inception in 2008, this journal has established itself as a vital resource for researchers, healthcare professionals, and students, offering a platform for the dissemination of high-quality research that improves the understanding and treatment of neurological disorders. With a commendable impact factor and ranked Q1 in multiple categories, including Neurology and Pharmacology for 2023, it exemplifies excellence in scholarly contributions. The journal's Scope encompasses a wide array of topics, providing insights that are pivotal for clinical practice and pharmacological development. Additionally, with its commitment to open access since 2017, Therapeutic Advances in Neurological Disorders ensures that its research reaches a global audience, fostering collaboration and innovation in neurological science.
Journal of Clinical Neurology
Empowering Clinicians with Cutting-edge ResearchThe Journal of Clinical Neurology, published by the Korean Neurological Association, is a prominent open-access journal that has been disseminating crucial findings in the field of neurology since its inception in 2008. With an ISSN of 1738-6586 and an E-ISSN of 2005-5013, this journal provides a vital platform for researchers and clinicians to share innovative research, reviews, and case studies that advance understanding and treatment of neurological disorders. The journal has established its reputation, achieving a Q3 ranking in Neurology and a Q2 ranking in Clinical Neurology in 2023, placing it among the noteworthy sources in the medical community. With its open-access format since 2011, it facilitates broad dissemination of knowledge to both the scientific community and the public, supporting the journal's mission to enhance clinical practice and promote neurological health in South Korea and beyond. As of October 2023, it holds influential Scopus ranks, reflecting its impact and relevance in the ever-evolving landscape of neuroscience. Researchers, professionals, and students alike are encouraged to contribute to and engage with the ongoing discourse by submitting their work and accessing a wealth of resources through this esteemed publication.
Aktualnosci Neurologiczne
Your Gateway to Cutting-Edge Neurological InsightsAktualnosci Neurologiczne is a renowned open-access journal dedicated to the field of neurology, published by Medical Communications. As a crucial platform for the dissemination of neurological research, it has been operational since 2005, fostering an inclusive environment for scientific discourse and innovation. With an ISSN of 1641-9227, the journal aims to bridge the gap between clinical practice and research, offering a diverse range of articles that cover the latest developments in neurological science. Although its coverage in Scopus was discontinued after 2017, the journal continues to maintain a robust archive of scholarly articles that contribute to understanding neurological disorders. Researchers, healthcare professionals, and students interested in the latest trends and studies in neurology will find Aktualnosci Neurologiczne an invaluable resource, providing insights that drive advancements in the field. The journal operates from its address in Warsaw, Poland, and invites contributions from the global research community to enrich its content and impact.